title: Cardiac calcium release channel (ryanodine receptor) in control and cardiomyopathic human hearts: mRNA and protein contents are differentially regulated.
abstract: Abnormal intracellular calcium handling in cardiomyopathic human hearts has been associated with an impaired function of the sarcoplasmic reticulum, but previous reports on the gene expression of the ryanodine receptors (Ry2) are contradictory. We measured the mRNA levels, the protein levels and the number of high affinity [3H]ryanodine binding sites in the left ventricle of non-failing (n = 9) and failing human hearts [idiopathic dilated (IDCM n = 16), ischemic (ICM n = 7) or mixed (MCM n = 8) cardiomyopathies]. Ry2 mRNA levels were significantly reduced in IDCM (-30%) and unchanged in MCM and ICM and Ry2 protein levels were similar. In contrast, we observed a two-fold increase in the number of high affinity Ry2 (B(max) = 0.43 +/- 0.11 v 0.22 +/- 0.13 pmol/mg protein, respectively; P<0.01) and an unchanged K(d). Furthermore, levels of myosin heavy chain mRNA and protein per g of tissue were similar in failing and non-failing hearts, suggesting that the observed differences in Ry2 are not caused by the increase in fibrosis in failing heart. Therefore, the dissociation between the two-fold increase in the number of high affinity ryanodine receptors observed in all failing hearts and the slightly decreased mRNA level or unchanged protein level suggests that the ryanodine binding properties are affected in failing myocardium and that such modifications rather than a change in gene expression alter the channel activity and could contribute to abnormalities in intracellular Ca2+ handling.
authors.affiliation: Unité 127 INSERM, IFR Circulation Lariboisière, Université D Diderot, Paris, France.
authors.forename: C
authors.initials: C
authors.lastname: Sainte Beuve
authors.forename: P D
authors.initials: PD
authors.lastname: Allen
authors.forename: G
authors.initials: G
authors.lastname: Dambrin
authors.forename: F
authors.initials: F
authors.lastname: Rannou
authors.forename: I
authors.initials: I
authors.lastname: Marty
authors.forename: P
authors.initials: P
authors.lastname: Trouvé
authors.forename: V
authors.initials: V
authors.lastname: Bors
authors.forename: A
authors.initials: A
authors.lastname: Pavie
authors.forename: I
authors.initials: I
authors.lastname: Gandgjbakch
authors.forename: D
authors.initials: D
authors.lastname: Charlemagne
mesh_terms: D000328:Adult; D001665:Binding Sites; D015153:Blotting, Western; D015220:Calcium Channels / Q000235:genetics* / Q000378:metabolism*; D009202:Cardiomyopathies / Q000378:metabolism*; D002311:Cardiomyopathy, Dilated / Q000378:metabolism; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009124:Muscle Proteins / Q000235:genetics* / Q000378:metabolism*; D017202:Myocardial Ischemia / Q000378:metabolism; D009206:Myocardium / Q000737:chemistry; D012323:RNA Processing, Post-Transcriptional; D012333:RNA, Messenger / Q000378:metabolism; D012433:Ryanodine / Q000378:metabolism; D019837:Ryanodine Receptor Calcium Release Channel; D014316:Tritium
chemical_list: D015220:Calcium Channels; D009124:Muscle Proteins; D012333:RNA, Messenger; D019837:Ryanodine Receptor Calcium Release Channel; D014316:Tritium; D012433:Ryanodine